TCTMD1h
‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials
A minority of studies used the standard three-point MACE endpoint, and many tweaked their endpoints along the way.
manilatimes6h
Neurona Unveils Phase 3 EPIC Study for NRTX-1001 Cell Therapy in Epilepsy
The Phase 3 EPIC trial is a randomized, sham-controlled, double-blind study evaluating NRTX-1001 cell therapy in adults with ...
Healio8h
Q&A: AI-supported breast cancer screening increases detection rate, reduces workload
AI-supported breast cancer screening increased early-stage cancer detection while reducing radiologists’ workload without increasing false positives, but more research is needed before clinical ...
Shape Memory Medical Announces European Enrollment in the AAA-SHAPE Randomized Controlled Pivotal Trial
Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular markets, announced the first enrollment in Europe in the AAA-SHAPE Pivotal Trial, the Company’s prospective, ...
ThePrint13h
As COVID Becomes a Permanent Reality, Focus Must Shift to Effective Treatment Options
As COVID-19 continues to evolve into new variants, it is clear that the virus is here to stay. With vaccines no longer at the center of public discourse and their safety is in question against ...
Platform trials streamline ALS therapy evaluation by rapidly ruling out ineffective drugs
Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...
The supplement that claims to improve brain fog and help prevent Alzheimer’s
You can add it to your coffee, cook it fresh or pop as a pill – but does this popular mushroom actually supercharge your ...
The Lancet23h
The ATTeST trial in ataxia telangiectasia: some concerns – Authors' response
We thank Michèl Willemsen and colleagues for their interest in the ATTeST trial of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia.1 The two doses studied in ...